159 related articles for article (PubMed ID: 19088050)
1. Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.
Wang W; Edington HD; Rao UN; Jukic DM; Radfar A; Wang H; Kirkwood JM
Clin Cancer Res; 2008 Dec; 14(24):8314-20. PubMed ID: 19088050
[TBL] [Abstract][Full Text] [Related]
2. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.
Wang W; Edington HD; Rao UN; Jukic DM; Land SR; Ferrone S; Kirkwood JM
Clin Cancer Res; 2007 Mar; 13(5):1523-31. PubMed ID: 17332298
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal roles of STAT3 and STAT5 in nasal polyposis.
Wang XQ; Hu GH; Kou W; Shen Y; Kang HY; Hong SL
Am J Otolaryngol; 2012; 33(6):741-52. PubMed ID: 22959364
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
5. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
6. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation.
Liu W; Li H; Zhang X; Wen D; Yu F; Yang S; Jia X; Cong B; Ma C
Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):335-44. PubMed ID: 24035274
[TBL] [Abstract][Full Text] [Related]
8. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
9. Therapy with omeprazole modulates regulatory T cell/T helper 17 immune response in children with duodenal ulcers.
Li CY; Wu C
Inflammopharmacology; 2018 Apr; 26(2):337-347. PubMed ID: 28735449
[TBL] [Abstract][Full Text] [Related]
10. Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome.
Zheng Y; Wang Z; Deng L; Zhang G; Yuan X; Huang L; Xu W; Shen L
Clin Immunol; 2015 Mar; 157(1):65-77. PubMed ID: 25572535
[TBL] [Abstract][Full Text] [Related]
11. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
[TBL] [Abstract][Full Text] [Related]
12. Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients.
Mozzillo N; Ascierto P
Clin Exp Metastasis; 2012 Oct; 29(7):801-5. PubMed ID: 22752507
[TBL] [Abstract][Full Text] [Related]
13. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells.
Wuest TY; Willette-Brown J; Durum SK; Hurwitz AA
J Leukoc Biol; 2008 Oct; 84(4):973-80. PubMed ID: 18653463
[TBL] [Abstract][Full Text] [Related]
14. Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.
Wang W; Edington HD; Jukic DM; Rao UN; Land SR; Kirkwood JM
Cancer Immunol Immunother; 2008 Sep; 57(9):1315-21. PubMed ID: 18386001
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract][Full Text] [Related]
16. Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints.
Fiocco U; Martini V; Accordi B; Caso F; Costa L; Oliviero F; Scanu A; Felicetti M; Frallonardo P; Facco M; Boso D; Molena B; Zambello R; Ramonda R; Cozzi F; Scarpa R; Basso G; Semenzato G; Dayer JM; Doria A; Punzi L
J Rheumatol Suppl; 2015 Nov; 93():48-52. PubMed ID: 26523057
[TBL] [Abstract][Full Text] [Related]
17. JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T Cells and Th17 cells.
Park JS; Lee J; Lim MA; Kim EK; Kim SM; Ryu JG; Lee JH; Kwok SK; Park KS; Kim HY; Park SH; Cho ML
J Immunol; 2014 May; 192(9):4417-24. PubMed ID: 24688026
[TBL] [Abstract][Full Text] [Related]
18. Imbalance of interleukin-17+ T-cell and Foxp3+ regulatory T-cell dynamics in rat periapical lesions.
Yang S; Zhu L; Xiao L; Shen Y; Wang L; Peng B; Haapasalo M
J Endod; 2014 Jan; 40(1):56-62. PubMed ID: 24331992
[TBL] [Abstract][Full Text] [Related]
19. Traffic-related PM
Wang C; Wang D; Zhao H; Wang J; Liu N; Shi H; Tian J; Wang X; Zhang Z
Int Immunopharmacol; 2021 Jul; 96():107788. PubMed ID: 34162152
[TBL] [Abstract][Full Text] [Related]
20. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.
Burchill MA; Yang J; Vogtenhuber C; Blazar BR; Farrar MA
J Immunol; 2007 Jan; 178(1):280-90. PubMed ID: 17182565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]